2014

Cell Therapeutics, Inc. (CTI) to update Pixuvri® launch and pacritinib pivotal trial status at the Annual Rodman & Renshaw Global Investment Conference

SEATTLE, Sept. 7, 2012 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) management will present at the Annual Rodman & Renshaw Global Investment Conference on Tuesday, September 11 at 10:25 a.m. Eastern/ 4:25 p.m. Central European/ 7:25 a.m. Pacific time in the Starlight North room of the Waldorf-Astoria Hotel.

The presentation with slides will be webcast live and available for replay after the presentation.  The webcast can be accessed at www.celltherapeutics.com.

Annual Rodman & Renshaw Global Investment Conference

CTI presentation: Tuesday, September 11, 2012

10:25 a.m. Eastern/ 4:25 p.m. Central European/ 7:25 a.m. Pacific

Starlight North, Waldorf-Astoria Hotel

Media contact:                

Investors contact:

Cell Therapeutics, Inc.                   

Cell Therapeutics, Inc.

Dan Eramian                   

Ed Bell

T: 206.272.4343                    

T: 206.272.4345

F: 206.272.4434                       

E: invest@ctiseattle.com

E: deramian@ctiseattle.com           

www.celltherapeutics.com/investors

www.celltherapeutics.com/press_room        


 

                                                                                         

SOURCE Cell Therapeutics, Inc.



RELATED LINKS
http://www.celltherapeutics.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.